Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 6/20 | 0.43 |
| ▸ | SLC6A9 | P48067 | 5/20 | 0.43 |
| ▸ | SLC6A5 | Q9Y345 | 4/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.43 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9733620 | 1.00 | OPRM1 (0.43) | OPRM1SLC6A9SLC6A5OPRL1SLC18A3 | |
| SCHEMBL9733623 | 1.00 | OPRM1 (0.43) | OPRM1SLC6A9SLC6A5OPRL1SLC18A3 | |
| SCHEMBL82208 | 0.99 | OPRM1 (0.42) | OPRM1SLC6A9SLC6A5OPRL1SLC18A3 | |
| SCHEMBL69255 | 0.99 | OPRM1 (0.42) | OPRM1SLC6A9SLC6A5OPRL1SLC18A3 | |
| SCHEMBL8448797 | 0.99 | OPRM1 (0.42) | OPRM1SLC6A9SLC6A5OPRL1SLC18A3 | |
| SCHEMBL82209 | 0.99 | OPRM1 (0.42) | OPRM1SLC6A9SLC6A5OPRL1SLC18A3 | |
| SCHEMBL31302597 | 0.99 | OPRM1 (0.42) | OPRM1SLC6A9SLC6A5OPRL1SLC18A3 | |
| SCHEMBL17207460 | 0.96 | OPRM1 (0.41) | OPRM1SLC6A9SLC6A5OPRL1SLC18A3 | |
| SCHEMBL15824257 | 0.93 | SLC6A9 (0.42) | OPRM1SLC6A9SLC6A5OPRL1SLC18A3 | |
| SCHEMBL15823874 | 0.87 | SLC6A9 (0.35) | OPRM1SLC6A9SLC6A5OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-60172970-A | — | — | None | — | — | JP | disclosed |
| US-20150307460-A1 | Substituted Triazoles and Imidazoles and Their Use as Fungicides | BASF SE (DE) | 2015-10-29 | — | — | US | disclosed |
| US-20150307460-A1 | Substituted Triazoles and Imidazoles and Their Use as Fungicides | BASF SE (DE) | 2015-10-29 | — | — | US | disclosed |
| WO-2014095547-A1 | NEW SUBSTITUTED TRIAZOLES AND IMIDAZOLES AND THEIR USE AS FUNGICIDES | BASF SE (DE) | 2014-06-26 | — | — | WO | disclosed |
| US-5091539-A | Reacting an ozolyl cycloalkanone with Grignard reagent or alkali metal compound | SHIONOGI & CO., LTD. (JP) | 1992-02-25 | — | — | US | disclosed |
| JP-S60172970-A | CIS-AZOLYLCYCLOALKANOL DERIVATIVE, ITS PREPARATION AND FUNGICIDE FOR AGRICULTURAL USE | SHIONOGI & CO LTD | 1985-09-06 | — | — | JP | disclosed |
| EP-0152031-A2 | Azolyl cycloalkanol derivatives and agricultural fungicides | SHIONOGI & CO., LTD. (JP) | 1985-08-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150307460-A1 | Substituted Triazoles and Imidazoles and Their Use as Fungicides | TH, CYP51A1, NOS3 | OPRM1 4317/4885SLC6A9 2695/4885SLC6A5 2381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.